Daphne Koller is the co-founder and CEO of Insitro, a biotechnology company that uses machine learning and AI to accelerate drug discovery. San Francisco-based Insitro, founded in 2018 ...
That includes Recursion – which made $436 million from its IPO – while Insitro and Insilico Medicine have made $400 million and $255 million, respectively, from their third rounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback